Discordant effect of aspirin and indomethacin on intestinal tumor burden inApcMin/+ mice
- 31 May 2000
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 62 (5) , 269-275
- https://doi.org/10.1054/plef.2000.0154
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppressionCarcinogenesis: Integrative Cancer Research, 1999
- Aspirin prevents tumors in a murine model of familial adenomatous polyposisSurgery, 1998
- Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin☆☆☆Gastroenterology, 1998
- Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosisProceedings of the National Academy of Sciences, 1998
- Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.Gut, 1996
- Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?Journal of Cellular Biochemistry, 1995
- Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 ratsCarcinogenesis: Integrative Cancer Research, 1993
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991
- Sulindac for polyposis of the colonJournal of Surgical Oncology, 1983
- [16] Protein determination in membrane and lipoprotein samples: Manual and automated proceduresPublished by Elsevier ,1981